Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flecainide CR vs placebo in first episode atrial fibrillation
2006-003211-40Phase 4Completed
- Sponsor
- 3M
- Start
- Dec 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Atrial fibrillation (AFib) comparing Flecainide CR with Placebo (2 arms). Primary endpoint: Time to first AF relapse. Started Dec 2006; status: completed.
02
Drugs
flecainide
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on 2006-003211-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003211-40.